Atypical Orofacial Pain Diagnostics and Differentiation.

Lithuanian University of Health Sciences150 enrolled

Overview

Orofacial pain is diagnosed for more than 1.9 percent of general population and for 0.3 percent origin of the facial pain is unknown. Commonly atypical facial pain is treated as a neurological condition without an emotional or psychiatric evaluation. Since atypical pain and mood affective disorders can be related, patients do not receive proper care for this condition. The aim of this study is to evaluate the relationship between atypical facial pain syndrome and affective mood disorders. We aim to assess patients' with no diagnosed organic pathology tendency towards anxiety, depression, sleep disorders and one of big five personality traits through self-rating questionnaires. We will compare the gathered data with biosensors from iMotions software.

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

DIAGNOSTIC

Masking

NONE

Enrollment

150

Conditions

Persistent Idiopathic Facial Pain

Interventions

Patients are asked to describe their disease (gathering of anamnesis) and to categorize their symptoms according to their strength. Furthermore, patients complete self-evaluating questionnaires: Visual analog scale, Hospital anxiety and depression scale, Pittsburgh sleep quality index, Big five personality traits questionnaire.

Eligibility

Sex: ALLMin age: 18 YearsMax age: 70 Years

Medical Language ↔ Plain English

Experimental group The experimental group will consist only of adult patients (18-70years old), who were clinically diagnosed with atypical pain syndrome (G50.1) after all diagnostic measures were performed. Inclusion criteria: * Adult patients (18-70years old) who were clinically diagnosed with atypical pain syndrome (G50.1). * Patients who accepted terms of this research and has signed informed consent form. * Patients were not previously diagnosed with a psychiatric disorder. Exclusion criteria: * A potential participant of the study is not able to comprehend information regarding this study's protocol in both written and verbal forms or fails/refuses to sign an informed consent form. * Patients who have a diagnosed organic pathology causing orofacial pain. * Patients who are diagnosed with systemic diseases which may interfere with the study or patients who present with head or neck oncology pathologies. * Patients who were previously diagnosed with a psychiatric disorder. Control group Control group will consist of patients who were subjected to maxillofacial fracture (any jaw unilateral fracture). These patients will be involved in this study if they are hospitalized/or have visited Lithuanian University of Health Sciences hospital Kaunas Clinics Department of maxillofacial surgery. Inclusion criteria: * Adult patients (18-70year old) who have been diagnosed with orofacial pain due to jaw fracture (S02.3, S02.4, S02.6). * Patients who have signed an informed consent form. * Patients who were not previously diagnosed with a psychiatric disorder. Exclusion criteria: * A potential participant of the study is not able to comprehend information regarding this study's protocol in both written and verbal forms or fails/refuses to sign an informed consent form. * Patients who are diagnosed with systemic diseases which may interfere with the study or patients who present with head or neck oncology pathologies. * Patients who were previously diagnosed with a psychiatric disorder.

Outcomes

Primary Outcomes

Visual analog scale

Patients evaluate their spontaneous episodic pain before assessing self-evaluating questionnaires. Patient pain will be assessed using a visual analogue scale of 0-10, zero being no pain, ten being an unbearable/unimaginable pain. The higher score may lead to a possibilty of developing mood disorders.